Study Evaluating ISM5411 Administered Orally to Healthy Volunteers

NCT06012578 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: ISM5411
DRUG: Placebo

Sponsor

InSilico Medicine Hong Kong Limited